medigraphic.com
ISSN 1561-3054 (Electronic)

2019, Number 3

<< Back Next >>

Rev Cubana Med Trop 2019; 71 (3)

Economic impact of dengue on patients and families

Reyes JA, Guzmán TG, Ramírez BR, Hernández MC, García MG, Torres DM, Martinez FR, Van der Stuyft P, Baly GA

Language: Spanish
References: 35
Page: 1-19
PDF size: 389.49 Kb.


ABSTRACT

Introduction: Health-related loss of quality of life among dengue patients and their relatives, and unforeseen family expenses incurred for this reason, have not been sufficiently studied in Cuba.
Objective: Describe the impact on quality of life, as well as the non-medical direct and indirect unforeseen expenses incurred by patients hospitalized with dengue and their relatives.
Method: A cost analysis study was conducted based on data provided by patients hospitalized with dengue in Salvador Allende Clinical Surgical Hospital and their relatives in November 2013. A closed-ended questionnaire of 173 questions was applied in January-February 2014. Estimation was made of average health-related loss of quality of life, direct non-medical costs and indirect costs.
Results: The 30-44 years age group was the most harshly affected during the episode. There was a predominance of the female sex (63.3%). Health-related quality of life decreased dramatically from an average 86.9 the day before the disease to 27.8 on the day when patients felt the worst. At the time of the interview, 51% of the patients perceived that they had not recovered from the disease. Mean hospital stay was 5 days. Unforeseen patient and family expenses rose to 61.24 CUC (CI 95%; 43.23-79.25 CUC), of which 66.2 % was spent on food and 13.6 % on transport. Average income loss was 25.30 CUC for patients and 4.50 CUC for relatives. Total average cost per patient was 89.25 CUC (CI 95% 67.33-110.29 CUC).
Conclusions: Evidence was found of loss of quality of life as a result of dengue. Unforeseen expenses were high, representing three times the mean salary in the province of Havana.


REFERENCES

  1. World Health Organization. Dengue and dengue haemorrhagic fever. Factsheet No. 117. Geneva: WHO; 2009 [access 2010/09/08]. Available from: http://www.who.int/mediacentre/factsheets/fs117/en/

  2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7.

  3. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16.

  4. Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, Vong S, et al. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis. 2010;4(11):e890.

  5. World Health Organization. Dengue and severe dengue. Fact Sheet No 117. Geneva: WHO; 2016 [access 2010/09/08]. Available from: http://www.who.int/csr/disease/dengue/en/

  6. Kouri GP, Guzman MG, Bravo JR, Triana C. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ. 1989;67(4):375-80.

  7. Guzman MG. Thirty years after the Cuban haemorrhagic dengue epidemic of 1981. MEDICC Rev 2012;14:46-51.

  8. Beatty ME, Beutels P, Meltzer MI, Shepard DS, Hombach J, Hutubessy R, et al. Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment. Am J Trop Med Hyg. 2011;84(3):473-88.

  9. Schwartz LM, Halloran ME, Durbin AP, Longini IM. The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine. 2015;33(29):3293-8.

  10. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic Impact of Dengue Illness in the Americas.Am J Trop Med Hyg. 2011;84(2):200-7.

  11. Shepard DS, Undurraga EA, Halasa YA. Economic and Disease Burden of Dengue in Southeast Asia. Plos Neg Trop Dis. 2013;7(2):e2055.

  12. Guzman MG, Triana C, Bravo J, Kouri G. The estimation of the economic damages caused as a consequence of the epidemic of hemorrhagic dengue in Cuba in 1981. Rev Cubana Med Trop. 1992;44(1):13-7.

  13. Valdes LG, Mizhrahi JV, Guzman MG. Economic impact of dengue 2 epidemic in Santiago de Cuba, 1997. Rev Cubana Med Trop. 2002;54(3):220-7.

  14. Rodríguez Valdés A, Arias Díaz Y, Gámez Sánchez D. Evaluación económica de la atención a pacientes en la epidemia de dengue. MEDISAN 2012 [acceso 8/09/2010];16:661-8. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192012000500003

  15. Baly A, Toledo ME, Rodriguez K, Benitez JR, Rodriguez M, Boelaert M, et al. Costs of dengue prevention and incremental cost of dengue outbreak control in Guantanamo, Cuba. Trop MedInt Health. 2012;17(1):123-32.

  16. Saha S, Gerdtham UG. Cost of illness studies on reproductive, maternal, newborn, and child health: a systematic literature review. Health Economics Review. 2013;2013;3(3):24-36. 17. Halasa YA, Shepard DS, Zeng W. Economic Cost of Dengue in Puerto Rico. Am J Trop Medi Hyg. 2012;86(5):745-752. doi:10.4269/ajtmh.2012.11-0784.

  17. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale Med Clin (Barc). 1999;112 (Suppl 1):79-85.

  18. Flessa S. Essentials of Health Economics. In: Dr.Oliver Razum, editor. Costing of Health Care Services in Developing Countries.A prerequisite for Affordability Sustainability and Efficiency. Heidelbrg: Peter Lang; 2009.

  19. Tarricone R. Cost-of-illness analysis. What room in health economics? Health Policy. 2006;77(77):51-63.

  20. Gold MR. Cost effectiveness in health and medicine. New York: Oxford University Press; 1996.

  21. Clark DV, Mammen MP, Nisalak A, Puthimethee V, Endy TP. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. Am J Trop Med Hyg. 2005;72(6):786-91.

  22. González D, Martínez R, Castro O. Evaluation of Some Clinical, Humoral and Imagenological Parameters in Patients of Dengue Haemorrhagic Fever Six Months after Acute Illness. Dengue Bulletin. 2005;29:79-84.

  23. Lum LCS, Suaya JA, Tan LH, Sah BK, Shepard DS.Quality of life of dengue patients.Am J Trop Med Hyg 2008;78(6):862-7.

  24. Turchi M, Nascimiento NE, Suaya JA, Siqueira J, Souza WV, Turchi MD, et al. Quality of Life among Adults with Confirmed Dengue in Brazil. Am J Trop Med Hyg. 2011;85(4):732-8.

  25. Torrance GW. Utility approach to measuring health-related quality of life. J Chron. Dis 1987. J Chron Dis. 1987;40(6):593-600.

  26. Murray CJL, Lopez AD. Quantifying Disability - Data, Methods and Results. Bull World Health Org. 1994;72(3):481-94.

  27. Meltzer MI, Rigau-Perez JG, Clark GG, Reiter P, Gubler DJ. Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. Am J Trop Med Hyg. 1998;59(2):265-71.

  28. Suaya JA, Shepard DS, Siqueira JB, Martelli CT, Lum LCS, Tan LH, et al. Cost of Dengue Cases in Eight Countries in the Americas and Asia: A Prospective Study. Am J Trop Med Hyg. 2009;80(5):846-55.

  29. Oficina Nacional de Estadísticas e Información. Anuario estadístico de Cuba 2014. Empleo y salarios. ONEI; La Habana; 2015 [acceso 21/05/2015]. Disponible en: http://www.one.cu/aec2014/07%20Empleo%20y%20Salarios.pdf

  30. Añez G, Balza R, Valero N, Larreal Y. Economic impact of dengue and dengue hemorrhagic fever in the State of Zulia, Venezuela, 1997-2003. Rev Panam Salud Púb. 2006;19(5):314-20.

  31. Halasa YA, Shepard DS, Zeng W. Economic Cost of Dengue in Puerto Rico. Am J Trop Med Hyg. 2012;86(5):745-52.

  32. García AEA. El sector agropecuario en Cuba y sus vínculos con el exterior. En: Domínguez JI, Villanueva OE, Espina PM, Barbería L, editores. Desarrollo económico y social en Cuba. Reformas emprendidas y desafíos en el siglo 21. México: Editorial Fondo de Cultura; 2012.

  33. Beaute J, Vong S. Cost and disease burden of Dengue in Cambodia. BMC Public Health. 2010;31;10(1):521.

  34. Baly A, Gonzalez K, Cabrera P, Popa JC, Toledo ME, Hernández C, et al. Incremental cost of implementing residual insecticide treatment with delthametrine on top of intensive routine Aedes aegypti control. Trop Med Int Health. 2016;21(5):597-602.

  35. García FA, Rodriguez SA, Marine AME, de Vos P, Van der Stuyfs P. Gastos asumidos por la familia durante el ingreso en el hogar. Rev Cubana Salud Pub. 2008;34(2).




2020     |     www.medigraphic.com